Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility

ORL

Volumn 64, Issue 3, 2002, Pages 206-212

  Varzim, Graça ^a   Monteiro, Eurico ^a   Silva, Regina ^a   Pinheiro, Carlos ^a   Lopes, Carlos ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Larynx cancer; NAT1; NAT2; Polymorphisms

Indexed keywords

ACYLTRANSFERASE;

ADULT; AGED; ALLELE; ANALYTIC METHOD; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PORTUGAL; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TUMOR LOCALIZATION;

ACETYLTRANSFERASES; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISOENZYMES; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 0036284211     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058026     Document Type: Article

References (24)

1. Effect of smoking and alcohol consumption on laryngeal cancer risk in coastal Texas
2. Epidemiology of squamous cell cancer of the head and neck
3. DNA adducts of chemical carcinogens
4. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules
5. Mechanisms of carcinogenesis induced by alkylating agents
6. Possible mechanisms of alterations in the capacities of carcinogen metabolyzing enzymes during schistosomiasis and their role in bladder cancer induction
7. Molecular mechanisms of slow acetylation of drugs and carcinogens in humans
8. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and NAT2 acetyltransferases
9. N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells
10. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus
11. Polyadenylation polymorphism in the acetyltransferase gene (NAT1) increases risk of colorectal cancer
12. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas
13. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk
14. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: The influence of smoking
15. Chemical and physical carcinogenesis: Advances and perspectives for the 1990s
16. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity
17. Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population
18. Polymorphic NATs and cancer predisposition
19. Role of aromatic amine acetyltransferases NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder
20. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans
21. Increased frequency of wild-type arylamine N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer
22. Genetic polymorphism of N-acetyltransferase 2, glutathione S-transferase M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer
23. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk
24. Review of studies of selected metabolic polymorphisms and cancer